Agents Used in Antiretroviral Therapy
Summary
- Fusion inhibitors block fusion of HIV with host cell membrane
- Currently only 1 fusion inhibitor approved by FDA: enfuvirtide (Table 16) Enfuvirtide
- Enfuvirtide, in combination with other antiretroviral agents, is indicated for treatment of HIV infection in treatment-experienced patients with evidence of HIV replication despite ongoing antiretroviral therapy[FDA Enfuvirtide]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content